Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension
NCT00638911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33247
Last updated 2012-05-21
Summary
The aim of this therapeutic observation is to demonstrate the efficacy and safety of telmisartan or telmisartan and HCTZ in the treatment of patients with mild-to-moderate essential hypertension under normal conditions of use after market launch.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
- Primary Completion
- 2009-10-31
More Related Trials
-
Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
NCT02238262 ·Status: COMPLETED
-
Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients
NCT02242851 ·Status: COMPLETED
-
Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers
NCT02262598 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects
NCT02187523 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
NCT02262858 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacovigilance and Patient Compliance in Hypertensive Patients
NCT02200575 ·Status: COMPLETED
-
Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers
NCT02276391 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
NCT00168779 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis
NCT02178306 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide
NCT02248129 ·Status: COMPLETED
-
Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers
NCT02262780 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers
NCT02262624 ·Status: COMPLETED ·Phase: PHASE1
-
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-I Treatment Due to couGH in Poland
NCT01211171 ·Status: COMPLETED
-
Micardis®. Observational Study in Patients With Essential Hypertension
NCT02200094 ·Status: COMPLETED
-
MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring
NCT02177396 ·Status: COMPLETED ·Phase: PHASE3
-
COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia
NCT01217879 ·Status: COMPLETED
-
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
NCT00471003 ·Status: COMPLETED
-
A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg
NCT00219115 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients
NCT00240448 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
NCT01289132 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
NCT00386139 ·Status: COMPLETED ·Phase: PHASE3
-
Candesartan Effect in Second Stage Arterial Hypertension
NCT00621153 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine
NCT00219154 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
NCT00872586 ·Status: COMPLETED ·Phase: PHASE3